Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
US5912013A · kind A · utility
114Cited by
12References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 21, 1995 |
| Grant date | Jun 15, 1999 |
| Priority date | — |
| Expiry date | Apr 21, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a composition and method of treating a patient by administering carbamazepine in a pharmaceutical dosage form capable of maintaining the patient's blood concentration at from about 4 .mu.g/ml to about 12 .mu.g/ml over at least a 12 hour period, where the blood concentration of carbamazepine does not vary by more than 60 percent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.